| | | | | | | | | | | | | | | | | | | | | | | |
|
|
|
|
| 2006D-0383
|
| Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FDA Comment Number :
|
| EC4142
|
|
|
|
|
| Submitter :
|
| Mrs. Juliet Stewart (U K)
|
| Date & Time:
|
| 12/22/2006 11:12:51
|
|
|
|
|
| Organization :
|
| Society for the Protection of Unborn Children
|
|
|
|
|
| Category :
|
| Individual Consumer
|
|
|
|
|
| Issue Areas/Comments
|
|
|
|
|
|
| GENERAL
|
|
|
|
|
|
|
|
| GENERAL
|
|
|
|
|
|
|
|
| The way forward for humanity is to use exclusively ethical cell lines, not derived from human foetus tissue.
|
|
|
|
|
|
|
|
|
|
|